Clinical trials
Phase 3 COVID-19 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 11 |
| 2021 | 7 |
| 2022 | 9 |
| 2023 | 7 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 16 |
| Completed | 13 |
| Recruiting | 3 |
| Terminated | 3 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 3 |
| Chinese Academy of Medical Sciences | 3 |
| Sinovac Research and Development Co., Ltd. | 3 |
| Capital Medical University | 2 |
| Gilead Sciences | 2 |
| Guangzhou Patronus Biotech Co., Ltd. | 2 |
| Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd | 2 |
| Shanghai Public Health Clinical Center | 2 |
| Ansun Biopharma, Inc. | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 37 |
| Coronavirus Infections | 6 |
| Pneumonia | 4 |
| Infections | 2 |
| Lung Diseases | 2 |
| Pneumonia, Pneumocystis | 2 |
| Respiratory Tract Infections | 2 |
| Virus Diseases | 2 |
| Coronaviridae Infections | 1 |
| Influenza, Human | 1 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.